Literature DB >> 27065662

Metastatic Malignant Phyllodes Tumor of the Breast: An Aggressive Disease-Analysis of 7 Cases.

Pooja Ramakant1, Marie M Therese2, M J Paul1.   

Abstract

Malignant phyllodes tumor (PT) of the breast behaves aggressively and the presentation of distant metastases is varied, ranging from synchronous or short interval commonly to a decade rarely. To assess the clinical and temporal pattern of distant metastases in malignant PTs. A retrospective analysis of patients with Phyllodes tumor of the breast from January, 2001 to November, 2014. There were a total of 167 patients with PT; 49 (29 %) were malignant PT out of which 7 developed distant metastases. Detailed analysis of these 7 patients showed that mean age was 36.71 years (range 28-53 years). Three of the seven patients had additional local recurrences post lumpectomy. The procedure performed were wide local excision with muscle reconstruction (n = 1), lumpectomy (n = 1) and mastectomy (n = 5). The distant metastases were synchronous (n = 2) and other 5 had metastases developing within 2 months to 13 years. The sites for distant metastases included lung, brain, adrenal, para-aortic nodes and bone. Six patients received palliative chemotherapy (CT) and 2 also had radiation therapy for brain metastasis. Only 1 patient is alive and receiving CT and all others succumbed to the disease. Patients with malignant PT of the breast with distant metastases behave aggressively and have a dismal outcome with rare exceptions. They need multimodality therapy and close follow up. Newer targeted therapies may have a role to improve the outcome.

Entities:  

Keywords:  Distant metastases; Malignant phyllodes tumor of breast

Year:  2015        PMID: 27065662      PMCID: PMC4809841          DOI: 10.1007/s13193-015-0397-9

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  18 in total

1.  Anemia and jejunal intussusception: An unusual presentation for a metastatic phyllodes breast tumor.

Authors:  Sidney A Schechet; Erik P Askenasy; Sagar Dhamne; Bradford G Scott
Journal:  Int J Surg Case Rep       Date:  2011-11-09

2.  Long-term outcomes of malignant phyllodes tumors patients: an institutional experience.

Authors:  Adora Fou; Freya R Schnabel; Diane Hamele-Bena; Xiao-Jun Wei; Bin Cheng; Mahmoud El Tamer; Laura Klein; Kathie Ann Joseph
Journal:  Am J Surg       Date:  2006-10       Impact factor: 2.565

3.  Osteogenic pulmonary metastases originating from a phyllodes tumour of the breast with osteosarcomatous differentiation.

Authors:  S K Bhartia; P Kashyap
Journal:  Australas Radiol       Date:  2005-02

4.  Pulmonary metastases 12 years after a mastectomy for borderline phyllodes tumor.

Authors:  Xiao-Meng Nie; Yang Wang; Xiao-Peng Yao
Journal:  Chin Med J (Engl)       Date:  2011-12       Impact factor: 2.628

5.  Metastatic phyllodes tumor causing small-bowel obstruction.

Authors:  Ronan J Kelly; Ciara Barrett; Niall Swan; Ray McDermott
Journal:  Clin Breast Cancer       Date:  2009-08       Impact factor: 3.225

6.  Surgical Resection of Phyllodes Tumour: a Radical Approach as a Safeguard Against Local Recurrence.

Authors:  Rajendra A Badwe; Kamal Kataria; Anurag Srivastava
Journal:  Indian J Surg       Date:  2013-06-26       Impact factor: 0.656

7.  Adrenal metastasis of a phyllodes tumor of the breast: Case report and review of the literature.

Authors:  Yves Collin; François Chagnon; Charles J Mongeau; Gonzalo L Gonzalez-Amaya; Lucas Sideris
Journal:  Int J Surg Case Rep       Date:  2013-05-14

8.  Surgical treatment of phyllodes tumors of the breast.

Authors:  B Salvadori; F Cusumano; R Del Bo; V Delledonne; M Grassi; D Rovini; R Saccozzi; S Andreola; C Clemente
Journal:  Cancer       Date:  1989-06-15       Impact factor: 6.860

9.  Challenges in management of phyllodes tumors of the breast: a retrospective analysis of 150 patients.

Authors:  P Ramakant; S Chakravarthy; J A Cherian; D T Abraham; M J Paul
Journal:  Indian J Cancer       Date:  2013 Oct-Dec       Impact factor: 1.224

10.  Comprehensive characterization of malignant phyllodes tumor by whole genomic and proteomic analysis: biological implications for targeted therapy opportunities.

Authors:  Denis L Fontes Jardim; Anthony Conley; Vivek Subbiah
Journal:  Orphanet J Rare Dis       Date:  2013-07-30       Impact factor: 4.123

View more
  7 in total

1.  Palliative Surgery for Metastatic Fungating Phyllodes Tumors: A Series of Two Cases.

Authors:  Aakanksha Goel; Rahul Insa; Manish Kumar Gaur; Pankaj Kumar Garg
Journal:  Perm J       Date:  2018

2.  Cutaneous Scalp Metastases of Malignant Phyllodes Tumor of the Breast.

Authors:  Hyo-Jae Lee; Hyo Soon Lim; So Yeon Ki; Jong Eun Lee; Ji Shin Lee; Min Ho Park
Journal:  J Breast Cancer       Date:  2020-02-27       Impact factor: 3.588

3.  Olaratumab administered in two cases of phyllodes tumour of the breast: end of the beginning?

Authors:  Anastasios Kyriazoglou; Flora Zagouri; Meletios A Dimopoulos
Journal:  ESMO Open       Date:  2019-06-25

4.  Phyllodes tumor with metastases to the skull managed with local excision: A case report.

Authors:  Ronak Patel; Arjun Mehta; Kabir Suri; Hillel Bocian; James Hu
Journal:  Rare Tumors       Date:  2019-11-26

5.  Malignant phyllodes tumor of the breast with metastases to the lungs: A case report and literature review.

Authors:  Edvin Ostapenko; Arvydas Burneckis; Andrej Ostapenko; Audronė Skaisgirytė; Valerijus Ostapenko
Journal:  Radiol Case Rep       Date:  2022-08-18

6.  Malignant phyllodes tumor with metastases to lung, adrenal and brain: A rare case report.

Authors:  Suman Khanal; Yogendra P Singh; Anuja Bhandari; Rashmi Sharma
Journal:  Ann Med Surg (Lond)       Date:  2018-11-02

7.  The treatment process of an extremely rare giant borderline phyllodes tumor of breast: case report and literature review.

Authors:  Qing Wang; Kai Zheng; Lei Zhang; Mingjian Tan; Hongwan Li; Hengyu Zhang; Dong Chen; Zhilin Li; Zhirui Chuan; Xi Wang; Yuanxiao Wang; Lei Zhe; Lijuan Liu; Dequan Liu; Rong Guo; Shicong Tang
Journal:  Transl Cancer Res       Date:  2021-04       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.